ArticleFrontiers in pharmacology2020

Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments.

Simone Perazzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.